drugset / Trial / NCT06009991

Summary

This is a multicenter, randomized, parallel, controlled clinical study of patients at different ages underwent elective non-cardiac surgery under general anesthesia. The aim of this study is to explore the dose range of remimazolam besylate for patients at different ages, to provide guidance for anesthesia induction and maintenance of remimazolam besylate. And to investigate the incidence of perioperative hypotension and postoperative related organ dysfunction in patients received total intravenous anesthesia with remimazolam besylate, compared with propofol.

Timeline

Start
2023-07-17
Primary completion
2025-09-30
Completion
2025-12-31

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Propofol Small molecule 1.5 ug/ml
Subject Propofol Small molecule 2.5 ug/ml
Subject Propofol Small molecule 3 ug/ml
Subject Remimazolam Small molecule 0.5 mg/kg Intravenous

Indications

No indication recorded.